Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin.

Drug Shortages Stem From Quality Problems in Indian Factories

Poor conditions at factories in India have sickened Americans and exacerbated chemotherapy-drug shortages for cancer patients,…

Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It

Health Teva, Allergan, CVS and Walgreens say enough states have agreed to finalize the deal, pouring…

Opinion | Why Cancer Drugs Are Being Rationed

The government squeeze on generic profits is leading to shortages.

Generic-Drug Developer Lannett Files For Bankruptcy

Generic-drug developer Lannett said it has filed for bankruptcy after reaching a deal with many of…

FDA Forces the Only Drug for Preterm Births to Leave Market

Health Agency says Makena injections ineffective for pregnant women with previous early birth

FDA forces only drug for preterm birth to leave market

Health Agency says Makena injection ineffective for pregnant women with previous early birth

Mark Cuban and Amazon Are Shaking Up Generic Drugs

Americans shudder at the thought of losing their health coverage, but bypassing giant insurers saves some…

Amazon Launches $5-a-Month Prescription Drug Plan in Further Healthcare Push

The new Prime membership benefit, dubbed RxPass, will provide unlimited access to commonly prescribed generic drugs.

World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen

Markets Heard on the Street As AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be…